Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 2,061 - 2,080 results of 12,940 for search '(( significantly increased decrease ) OR ( significant ((side decrease) OR (teer decrease)) ))', query time: 0.35s Refine Results
  1. 2061
    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.

    Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2062
    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.

    Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2063
    Variables obtained from the SF-36 quality of life questionnaire in each experimental group.

    Variables obtained from the SF-36 quality of life questionnaire in each experimental group. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2064
    Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models.

    Line graph showing the values of myocardial perfusion defects in the study groups. p = ANOVA Mixed Models. by Káryta Suely Macêdo Martins (22404155)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2065
    Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions.

    Decomposition analysis of the changes in prevalence (A), DALYs (B), and mortality (C) rates of IBD among women across global, 5 SDI and 21 GBD regions. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2066
    Health inequalities in the burden of IBD among WCBA.

    Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2067
    Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040.

    Estimated prevalence (A), DALYs (B), and mortality (C) rates for IBD among WCBA by 2040. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2068
    The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021.

    The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2069
    Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040.

    Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2070
    The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021.

    The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2071
    Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions.

    Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2072
    Supporting information.

    Supporting information. by Yu Sang Choi (22656230)

    Published 2025
    “…Also, the Chao1 index for richness were remarkably decreased in both MP-treated Lep KO and WT mice, but Shannon index for evenness were increased in only MP-treated Lep KO mice. …”
    Save to List
    Saved in:
  13. 2073
    This is the raw data used for this study.

    This is the raw data used for this study. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2074
    Pre-operative versus post-operative symptoms.

    Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2075
    The Human Disharmony Loop (full) Including Inciting Factors.

    The Human Disharmony Loop (full) Including Inciting Factors. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2076
    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup>

    Baseline Severity of Disease by Scapular Dyskinesia Stage<sup>1.</sup> by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2077
    The Human Disharmony Loop Clinical Presentation.

    The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2078
    Patient Demographics.

    Patient Demographics. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2079
    Pain and Function Outcomes Following PM Tenotomy.

    Pain and Function Outcomes Following PM Tenotomy. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2080
    Diagnostic Criteria for Human Disharmony Loop.

    Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: